Sachs J R, Welt L G
J Clin Invest. 1968 Apr;47(4):949-59. doi: 10.1172/JCI105787.
The active potassium influx in the human red blood cell is inhibited by strophanthidin, ethacrynic acid, and MK-870 (a new diuretic), and the degree of inhibition is greater at low concentrations of extracellular potassium than at high. In the case of ethacrynic acid, potassium appears to diminish the rate of combination of the drug with the transport system. The kinetic behavior of the active potassium influx in the presence of the inhibitors strophanthidin and ethacrynic acid is consistent with a model in which the binding of potassium at one of the potassium-sensitive sites in the transport system reduces the affinity of the system for the drug, and binding of a second potassium ion further reduces the affinity. It is not possible to distinguish between the sites on the basis of the studies presented here.
毒毛花苷、依他尼酸和MK - 870(一种新型利尿剂)可抑制人体红细胞中的主动钾内流,且在细胞外钾浓度较低时的抑制程度大于浓度较高时。就依他尼酸而言,钾似乎会降低药物与转运系统的结合速率。在存在抑制剂毒毛花苷和依他尼酸的情况下,主动钾内流的动力学行为与一种模型相符,即转运系统中一个钾敏感位点上钾的结合会降低系统对药物的亲和力,而第二个钾离子的结合会进一步降低亲和力。根据此处所呈现的研究,无法区分这些位点。